FDA Drug Application (090721) for FALMINA by NOVAST LABS LTD

Back to FDA Applications sponsored by NOVAST LABS LTD

Application Number090721
Product Number001
FormTABLET;ORAL-28
Dosage0.02MG;0.1MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameFALMINA
Active IngredientETHINYL ESTRADIOL; LEVONORGESTREL

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient LEVONORGESTREL58


Back to FDA Applications sponsored by NOVAST LABS LTD